Latest News
Kain Capital LLC, a private equity firm focused on the technology enablement of healthcare services companies, has moved into new office space at One World Trade Center in New York City. This marks the firm’s return to a physical location after staff worked remotely during the Covid-19 pandemic.
To date, Kain has invested in five healthcare subsectors including value-based primary care, hospice & palliative care, occupational medicine & worker’s compensation, specialised behavioural health services, and healthcare technology, and will consider other areas as opportunities arise.
The firm’s investment scope is national, and it currently has investments in 10 states. Its
General Atlantic, a global growth equity firm, has appointed Mark Stevenson as a Senior Advisor. In his new role, Stevenson will provide strategic counsel and support to the firm’s investment teams and portfolio companies in the life sciences sector.
Stevenson brings more than three decades of experience and significant leadership experience in the sector, most recently serving as executive vice president and chief operating officer at Thermo Fisher Scientific, a Fortune 100 company providing life science solutions, analytical instruments, specialty diagnostics and pharma services with over $40 billion in sales annually. He was responsible for the company’s portfolio of life
Dechert LLP has appointed private equity fund lawyer Sam Kay as a partner in the firm’s financial services and investment management practice in London.
With over 25 years of experience advising on investment funds, Kay specialises in fund formation work for a wide range of private funds and asset management clients in the private equity, private debt/credit, infrastructure, and real estate sectors. He also regularly works on GP-led transactions and secondaries (both buy-side and sell-side), carried interest arrangements and co-investment schemes.
Kay has been recognised as a “Global Leader” for private fund formation by Who’s Who Legal and ranked in
STG, a private equity firm focused on investing in software and software-enabled technology services businesses, has held the final closing of STG VII with total capital commitments of $4.2 billion, including approximately $4.0 billion of limited partner commitments.
Private investment firm Bain Capital has made a non-binding buyout offer to acquire Australian senior care provider Estia Health Ltd for AUD775.1 million ($517.77 million), according to a report by Reuters, sending shares in the Sydney-based business to a three-year high.
Private markets specialist Portfolio Advisors has held the final close of the Portfolio Advisors Private Equity Fund XI at just over $1 billion in limited partner commitments. The fund was oversubscribed and surpassed its original target of $750 million.
Oldenburgische Landesbank AG, a German lender backed by private equity firm Apollo Global Management, has but the brakes on plans for an IPO that was expected to happen as early as May of this year, according to a report by Bloomberg.
Multinational law firm Cleary Gottlieb Steen & Hamilton has added to its private equity practice in London with the appointment of leveraged finance specialist Ed Aldred as a partner.
Aldred joins from Linklaters where he spent over 20 years – the past five as co-head of the firm’s financial sponsor leveraged finance practice.
Aldred has expertise across the spectrum of debt products and in several key financial jurisdictions, including London, Dubai, Hong Kong and Singapore, with a particular emphasis on leverage finance and loan/bond structures.
An affiliate of alternative investment firm HIG Capital has sold Elekeiroz, a specialist in the oxo-alcohols, plasticizers, phthalic & maleic anhydrides and sulfuric acid markets in Brazil, to Latin American speciality chemicals company Oswaldo Cruz Química.
Investment research company Third Bridge has launched Community a new product offering providing hedge find, private equity firms, credit investors, mutual funds, and strategy consultants access to transcribed interviews between investors and industry experts.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
